Finzati - Logo
PPBT logo

Purple Biotech Ltd.

PPBTBiotechnology
Strong market move
PPBT-11.62%
vs. previous close $1.98
$1.75
-0.23 (-11.62%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$197,460
Growth
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.03Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 15, 2026, 12:00 AM UTCLast profile update: Aug 9, 2026, 12:18 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1.75
Change-11.62%
Market Cap$197.46K
52W Range1.16 - 24.00
Beta-0.55
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.03
Current Ratio1.27
Quick Ratio1.27
Volume49.23K

Investment DNA

How strong this company looks for long-term investors

47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
66/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score
Manageable debt level · 0.03Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 11/20/2015
Industry: Biotechnology
P/B i: 0.00
Debt / Equity i: 0.03
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score13 / 20
Debt / Equity: 0.03
Current Ratio: 1.27
Quick Ratio: 1.27
Status: Good

Insider Transactions

Recent executive and insider activity

Rock Simcha
Transaction: 03/18/2026
OTHER
Change
+2,650,000
Price
Not reported
Filing
04/17/2026
Type
OTHER
Rock Simcha
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
04/17/2026
Type
OTHER
Zilberberg Suzana
Transaction: 03/18/2026
OTHER
Change
+2,650,000
Price
Not reported
Filing
04/07/2026
Type
OTHER